Gritti, G., Belousov, A., Relf, J., Dixon, M., Tandon, M., Komanduri, K. (2024). Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma. BLOOD ADVANCES, 8(14), 3615-3618 [10.1182/bloodadvances.2023011089].

Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma

Gritti G.;
2024

Lettera in rivista
CD20 antigen; glofitamab; lactate dehydrogenase; obinutuzumab; rituximab
English
10-lug-2024
2024
8
14
3615
3618
none
Gritti, G., Belousov, A., Relf, J., Dixon, M., Tandon, M., Komanduri, K. (2024). Predictive model for the risk of cytokine release syndrome with glofitamab treatment for diffuse large B-cell lymphoma. BLOOD ADVANCES, 8(14), 3615-3618 [10.1182/bloodadvances.2023011089].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/529681
Citazioni
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
Social impact